🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to characterize the effect of hepatic impairme...
Status
Completed
Location
University of Miami Division of Clinical Pharmacology
Start Date
2019-07-19
Trial ID
NCT04016077
Treatments Being Tested
This is a Phase 1, 2-period, multiple-dose, open-label, single fixed sequen...
Status
Completed
Location
New Haven Clinical Research Unit
Start Date
2021-11-02
Trial ID
NCT05097716
Treatments Being Tested
This is a Phase 1 non-randomized, open-label, parallel cohort study of PF-0...
Status
Terminated
Location
Investigational Drug Services (IDS) University of Miami Hospitals and Clinics
Start Date
2019-08-19
Trial ID
NCT04037865
Treatments Being Tested
This is a Phase 1, randomized, 2 way crossover, open-label study of the eff...
Status
Completed
Location
Quotient Sciences Screening Office
Start Date
2019-08-09
Trial ID
NCT04018274
Treatments Being Tested
This is an open label, single arm study in healthy Chinese male and/or fema...
Status
Completed
Location
Peking University Third Hospital
Start Date
2020-10-15
Trial ID
NCT04634565
Treatments Being Tested
This is a Phase 1, randomized, 2 way crossover, multiple dose, open label s...
Status
Completed
Location
Quotient Sciences
Start Date
2018-09-21
Trial ID
NCT03608241
Treatments Being Tested
This study will estimate the impact of a strong CYP3A4 inhibitor (itraconaz...
Status
Completed
Location
Pfizer Clinical Research Unit
Start Date
2019-02-21
Trial ID
NCT03821493
Treatments Being Tested
A phase 1, 2-period, fixed-sequence, multiple-dose, open-label study of the...
Status
Completed
Location
Brussels Clinical Research Unit
Start Date
2019-09-26
Trial ID
NCT04092595
Treatments Being Tested